Skip to main content
Livermore
Livermore
ZHEN

D.A. Davidson & Co.

SEC CIK
0001080107
Latest filing
Jul 24, 2026

ELV holding history

Elevance Health, Inc. in every 13F filed by D.A. Davidson & Co., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ELV overviewAll 13F holders of ELVFull Q2 2026 holdings

Shares (Q2 2026)
4,220
Value
$1.63M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of ELV by D.A. Davidson & Co., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20264,220$1.63M<0.1%−261−5.8%ReducedHolders
Q1 20264,481$1.31M<0.1%−1,139−20.3%ReducedHolders
Q4 20255,620$1.97M<0.1%+231+4.3%AddedHolders
Q3 20255,389$1.74M<0.1%+532+11.0%AddedHolders
Q2 20254,857$1.89M<0.1%−612−11.2%ReducedHolders
Q1 20255,469$2.38M<0.1%−47−0.9%ReducedHolders
Q4 20245,516$2.03M<0.1%−282−4.9%ReducedHolders
Q3 20245,798$3.02M<0.1%−122−2.1%ReducedHolders
Q2 20245,920$3.21M<0.1%−314−5.0%ReducedHolders
Q1 20246,234$3.23M<0.1%+577+10.2%AddedHolders
Q4 20235,657$2.67M<0.1%+69+1.2%AddedHolders
Q3 20235,588$2.43M<0.1%−63−1.1%ReducedHolders
Q2 20235,651$2.51M<0.1%−392−6.5%ReducedHolders
Q1 20236,043$2.78M<0.1%+1,007+20.0%AddedHolders
Q4 20225,036$2.58M<0.1%−180−3.5%ReducedHolders
Q3 20225,216$2.37M<0.1%+48+0.9%AddedHolders
Q2 20225,168$2.49M<0.1%−1,039−16.7%ReducedHolders
Q1 20226,207$3.05M<0.1%+30+0.5%AddedHolders
Q4 20216,177$2.86M<0.1%−370−5.7%ReducedHolders
Q3 20216,547$2.44M<0.1%+186+2.9%AddedHolders
Q2 20216,361$2.43M<0.1%−311−4.7%ReducedHolders
Q1 20216,672$2.40M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.